Evaluate the utility of using CD69 expression as an indicator of T cell activation following polyclonal T cell activation using mitogens (pHA, ConA) and monoclonal antibodies (CD2/CD2R) as activators. Compare the expression of CD69 to other activation antigens including CD25, CD71, HLA- DR at various time points following activation as well as comparing to tritiated thymidine incorporation at the end of the culture period.

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL010256-01
Application #
5201211
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code